BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 30448463)

  • 1. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
    Ahn SJ; Joung J; Lee BR
    Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TOXIC EFFECTS OF HYDROXYCHLOROQUINE ON THE CHOROID: Evidence From Multimodal Imaging.
    Ahn SJ; Ryu SJ; Lim HW; Lee BR
    Retina; 2019 May; 39(5):1016-1026. PubMed ID: 29373341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical Coherence Tomography Protocols for Screening of Hydroxychloroquine Retinopathy in Asian Patients.
    Ahn SJ; Joung J; Lim HW; Lee BR
    Am J Ophthalmol; 2017 Dec; 184():11-18. PubMed ID: 28964805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Retromode Imaging for Use in Hydroxychloroquine Retinopathy.
    Ahn SJ; Lee SU; Lee SH; Lee BR
    Am J Ophthalmol; 2018 Dec; 196():44-52. PubMed ID: 30118686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
    Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
    Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
    Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of OCT Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening.
    Kim KE; Ahn SJ; Woo SJ; Park KH; Lee BR; Lee YK; Sung YK
    Ophthalmology; 2021 Jan; 128(1):110-119. PubMed ID: 32553941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Hydroxychloroquine Retinopathy Using Ultra-Widefield Fundus Autofluorescence: Peripheral Findings in the Retinopathy.
    Ahn SJ; Joung J; Lee BR
    Am J Ophthalmol; 2020 Jan; 209():35-44. PubMed ID: 31526798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy.
    Solberg Y; Dysli C; Möller B; Wolf S; Zinkernagel MS
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):2165-2172. PubMed ID: 31108547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choroidal Thinning Associated With Hydroxychloroquine Retinopathy.
    Ahn SJ; Ryu SJ; Joung JY; Lee BR
    Am J Ophthalmol; 2017 Nov; 183():56-64. PubMed ID: 28890078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy.
    Ahn SJ; Seo EJ; Kim KE; Kim YJ; Lee BR; Kim JG; Yoon YH; Lee JY
    Ophthalmology; 2021 Jun; 128(6):889-898. PubMed ID: 33129843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
    JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
    Garrity ST; Jung JY; Zambrowski O; Pichi F; Su D; Arya M; Waheed NK; Duker JS; Chetrit Y; Miserocchi E; Giuffrè C; Kaden TR; Querques G; Souied EH; Freund KB; Sarraf D
    Br J Ophthalmol; 2019 Nov; 103(11):1600-1604. PubMed ID: 30819690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of disease stage on progression of hydroxychloroquine retinopathy.
    Marmor MF; Hu J
    JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perifoveal interdigitation zone loss in hydroxychloroquine toxicity leads to subclinical bull's eye lesion appearance on near-infrared reflectance imaging.
    Chew AL; Sampson DM; Chelva E; Khan JC; Chen FK
    Doc Ophthalmol; 2018 Feb; 136(1):57-68. PubMed ID: 29124422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SEQUENTIAL CHANGES IN HYDROXYCHLOROQUINE RETINOPATHY UP TO 20 YEARS AFTER STOPPING THE DRUG: Implications for Mild Versus Severe Toxicity.
    Pham BH; Marmor MF
    Retina; 2019 Mar; 39(3):492-501. PubMed ID: 30550532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF; Melles RB
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SD-OCT As screening test for hydroxychloroquine retinopathy: The «flying saucer» sign].
    Asensio-Sánchez VM
    Arch Soc Esp Oftalmol; 2015 Jul; 90(7):338-40. PubMed ID: 25443193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swept source optical coherence tomography angiography in patients treated with hydroxychloroquine: correlation with morphological and functional tests.
    Forte R; Haulani H; Dyrda A; Jürgens I
    Br J Ophthalmol; 2021 Sep; 105(9):1297-1301. PubMed ID: 30842084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.
    Rodriguez-Padilla JA; Hedges TR; Monson B; Srinivasan V; Wojtkowski M; Reichel E; Duker JS; Schuman JS; Fujimoto JG
    Arch Ophthalmol; 2007 Jun; 125(6):775-80. PubMed ID: 17562988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.